News Archive
Pioneering Advances in Cell Therapy: Kristin Yarema, President & CEO of Poseida Therapeutics
|
November 20, 2024
Bhagirathbhai R. Dholaria, MD, on Evaluating Allogeneic CAR-T P-BCMA-ALLO1 in R/R Multiple Myeloma
|
November 17, 2024
CAR-T and Related Therapies Home In on Autoimmune Disease
|
November 4, 2024
Roche-Poseida Lead Allogeneic CAR-T Advances after Showing Promise in Multiple Myeloma
|
October 2, 2024
Coming Soon: An Off-the-Shelf CAR T Therapy for Myeloma
|
October 2, 2024
“Off-the-Shelf” CAR T Therapy Strikes Hard Against Relapsed Myeloma
|
September 30, 2024
P-BCMA-ALLO1 May Be Safe, Rapid, and Active Allogeneic CAR T-Cell Therapy in Pretreated R/R Myeloma
|
September 30, 2024
Poseida shares incremental Phase 1 update for Roche-partnered off-the-shelf CAR-T
|
September 30, 2024
The Allogeneic Future with Poseida’s Kristin Yarema, Ph.D.
|
August 5, 2024
Eight companies tackling cancer with allogeneic cell therapy in 2024
|
June 13, 2024
Creating CAR T therapies that don’t cause cancer
|
February 16, 2024
